The global pancreatic enzymes market size was US$ 169 million in 2021. The global pancreatic enzymes market is forecast to grow to US$ 499.1 million by 2030 by growing at a compound annual growth rate (CAGR) of 12.8% during the forecast period from 2022 to 2030. 

Pancreatic enzymes are a combination of digestive enzymes produced by the pancreas' exocrine cells. This mixture is used to treat illnesses characterized by a lack of pancreatic secretions, such as cystic fibrosis, pancreatitis, and pancreatectomy. 

Factors Influencing the Market

The rising demand for pancreatic enzyme supplements is driving the growth of the global pancreatic enzymes market during the forecast period. Cystic Fibrosis Foundation (CFF) estimates that around 87 percent of cystic fibrosis patients need pancreatic enzyme supplements. The intestine in these patients lacks the enzymes, which are required to digest and absorb nutrients. Thus, the growing number of such cases are forecast to fuel the growth of the global pancreatic enzymes market during the study period. 

Rising awareness about gastrointestinal disorders and increasing awareness about health will benefit the global pancreatic enzymes market. In addition, growing urbanization and increasing consumption of fast food will surge the growth of the global pancreatic enzymes market. 

The growing number of digestive problems are forecast to benefit the global pancreatic enzymes market during the forecast period. 

The increasing number of partnerships and other expansion strategies will benefit the overall pancreatic enzymes industry during the forecast period. 

COVID-19 Impact Analysis

The sudden wake of the COVID-19 pandemic has negatively affected the global pancreatic enzyme market. The demand for fast food and other products decreased drastically due to the pandemic. In addition, sudden quarantine rules negatively impacted the global pancreatic enzymes market. 

Regional Analysis

Asia-Pacific is predicted to hold the highest share in the global pancreatic enzymes market. The factors attributed to market expansion are the expanding population suffering from digestion problems, unhealthy lifestyles, and rising awareness about eating healthily and staying healthy.

The pancreatic enzymes industry is expected to witness significant growth in North America. The growth of the region is attributed to the growing aging population and rising demand for preventative medicines. In addition, the rising consumption of packaged food products is likely to fuel the industry's growth. National Institute of Health (NIH) estimates that around 60-70 million people have suffered from digestive disorders in 2009 in the United States. Thus, the data indicate that pancreatic enzymes are in high demand in the region.

Competitors in the Market

• BIOZYM
• Spectrum Chemicals
• Chongqing Aoli
• Biocatalyst
• Bovogen Biologicals
• Geyuan Tianrun
• Allergan Pharmaceuticals International Limited
• VIVUS, Inc.
• Scientific Protein Laboratories LLC
• Kin Master Product Quimicos LTDA
• Other Prominent Players

Market Segmentation

The global pancreatic enzymes market segmentation focuses on Product, Application, and Region. 

Based on product type, the pancreatic enzyme market is segmented into –

• Pancreatic Pellets
• Pancreatic Powder

Based on application, the pancreatic enzyme market is segmented into –

• Pharma Industry
• Food Processing
• Others

Based on region, the pancreatic enzyme market is segmented into –

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America